The purpose of this proposed rule is only to repeal provisions which are now under the authority of the Optometry Examining Board per 2005 Wisconsin Act 297. The rule will not modify the pharmaceutical agents in the current rule nor create new policy. 4. Detailed explanation of statutory authority for the rule (including the statutory citation and language):
Section 449.17(5), Wis. Stats., states “the secretary shall, after consultation with the [optometry] examining board, the medical examining board and the pharmacy examining board, promulgate rules specifying the topical ocular diagnostic pharmaceutical agents which optometrist may utilize in this state.” Section 449.18(6)(cm), Wis. Stats., “the secretary shall, after consultation with the [optometry] examining board, the medical examining board and the pharmacy examining board, promulgate rules specifying those therapeutic pharmaceutical agents that may or may not be prescribed or administered.” 5. Estimate of amount of time that state employees will spend developing the rule and of other resources necessary to develop the rule:
60 hours
6. List with description of all entities that may be affected by the proposed rule:
Optometrists
7. Summary and preliminary comparison with any existing or proposed federal regulation that is intended to address the activities to be regulated by the proposed rule:
None
8. Anticipated economic impact of implementing the rule (note if the rule is likely to have a significant economic impact on small businesses):
None to minimal. It is not likely to have a significant economic impact on small businesses.
Contact Person:
Helen Leong, Administrative Rules Coordinator
Division of Policy Development, Department of Safety and Professional Services
(608) 266 – 0797
